Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositions
US12163150B2 · kind B2 · utility
0Cited by
5References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 5, 2020 |
| Grant date | Dec 10, 2024 |
| Priority date | — |
| Expiry date | Dec 29, 2042 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a recombinant measles virus expressing a heterologous amino acid sequence derived from an antigen of a determined RNA virus, said recombinant measles virus being capable of eliciting a humoral and/or cellular immune response against measles virus or against said RNA virus or against both measles virus and against said RNA virus. It also relates to the use of said recombinant measles virus for the preparation of immunogenic composition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.